<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23499">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02800863</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10113</org_study_id>
    <nct_id>NCT02800863</nct_id>
  </id_info>
  <brief_title>TARGET Post-Approval Study</brief_title>
  <acronym>TARGET PAS</acronym>
  <official_title>TARGET: A Post-Approval Study to Evaluate Targeted SCS Spinal Cord Stimulation (SCS) Dorsal Root Ganglion (DRG) Stimulation for the Management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs Due to CRPS Types I and II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective, multicenter, single arm post-approval study is to
      demonstrate continued safety of the Axium Neurostimulator System for dorsal root ganglion
      (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for
      permanent implants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A maximum of 376 adult subjects with moderate to severe chronic, intractable, pain of the
      lower limbs due to CRPS types I and II will undergo a trial of the Axium Neurostimulator
      System across 40 study sites in the United States. Only subjects who report a 50% or greater
      reduction in overall pain intensity through direct patient-reported percentage of pain
      relief will receive the permanent implant. Subjects will then return to the office for
      follow-up at 1, 3, 6 and 12 months post-permanent implant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Serious Adverse Events (SAEs)</measure>
    <time_frame>throughout 12 month study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent change from baseline to 12 months post-permanent implant for overall pain intensity measured using the Visual Analog Scale (VAS)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to 12 months post-permanent implant for physical function measured using the PROMIS Physical Function Scale</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to 12 months post-permanent implant for quality of life measured using the PROMIS Global Health Scale</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">376</enrollment>
  <condition>Complex Regional Pain Syndrome (CRPS)</condition>
  <arm_group>
    <arm_group_label>Dorsal Root Ganglion (DRG) Stimulation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System)</intervention_name>
    <description>Electrical stimulation of the DRG using the Axium™ Neurostimulator System</description>
    <arm_group_label>Dorsal Root Ganglion (DRG) Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult subjects aged 22 to 75 with moderate to severe chronic, intractable, pain of the
        lower limbs due to CRPS types I and II with a baseline VAS score of 6 or greater.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is male or female between 22 and 75 years of age.

          -  Subject has moderate to severe chronic intractable pain of the lower limbs resulting
             from Complex Regional Pain Syndrome (CRPS) types I or II.

          -  Subject has a baseline VAS score of &gt; 60 mm for overall pain at the time of the
             baseline assessment.

          -  Subject is willing and able to comply with the study requirements.

          -  Subject is able to provide written informed consent.

        Exclusion Criteria:

          -  Subject has an active implantable medical device including but not limited to cardiac
             pacemakers and cardiac defibrillators.

          -  Subject is currently involved in medically related litigation, including workers
             compensation.

          -  Subject has previously failed (i.e. did not receive &gt; 50% pain relief) spinal cord
             stimulation.

          -  Subject has a life expectancy of less than one year.

          -  Subject is pregnant or of child bearing potential and not using adequate
             contraception as determined by the investigator.

          -  Subject has, or plans to have, a spinal cord stimulation system or infusion pump
             system implanted.

          -  Subject has, or plans to have, a peripheral nerve stimulation system (PNS) or
             peripheral nerve field stimulation system (PNfS) implanted.

          -  Subject is considered to be a poor surgical or study candidate, which may include,
             but is not limited to the following: any medical, social, or psychological problem
             that could complicate the implant procedure and/or recovery from the implant
             procedure or could complicate the required procedures and evaluations of the study in
             the judgment of the investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Holly Fontenot</last_name>
    <phone>9725264828</phone>
    <email>hfontenot@sjm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arizona Pain Specialists</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ted Swing, PhD</last_name>
      <phone>480-245-6138</phone>
      <email>TedS@arizonapain.com</email>
    </contact>
    <investigator>
      <last_name>Jon Carlson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Summit Pain Alliance Inc.</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leny Engman</last_name>
      <phone>707-623-9803</phone>
    </contact>
    <investigator>
      <last_name>Jason Pope, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Front Range Pain Medicine</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80528</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charleen Wiley</last_name>
      <phone>970-495-0506</phone>
    </contact>
    <investigator>
      <last_name>George Girardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Pain Institute</name>
      <address>
        <city>Merritt Island</city>
        <state>Florida</state>
        <zip>32953</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Clark</last_name>
      <phone>321-784-8211</phone>
      <phone_ext>1125</phone_ext>
      <email>susanclarkflp@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Michael Esposito, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Robinson, MBA</last_name>
      <phone>312-942-2985</phone>
      <email>Sherry_J_Robison@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Timothy Lubenow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Goodman Campbell Brain &amp; Spine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacie Gren, RN,BSN</last_name>
      <phone>317-396-1354</phone>
      <email>sgren@goodmancampbell.com</email>
    </contact>
    <investigator>
      <last_name>Derron Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Pain Care</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Pamblanco</last_name>
      <phone>702-932-0606</phone>
    </contact>
    <investigator>
      <last_name>Michael Fishell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nevada Advanced Pain Specialists</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachael Yetter</last_name>
      <phone>775-284-8650</phone>
      <email>rachael@nvadvancedpain.com</email>
    </contact>
    <investigator>
      <last_name>Denis Patterson</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ali Nairizi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Pain Centers</name>
      <address>
        <city>Shrewsbury</city>
        <state>New Jersey</state>
        <zip>07702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandy Mead</last_name>
      <phone>732-930-2423</phone>
      <email>mmead@premierpain.com</email>
    </contact>
    <investigator>
      <last_name>Peter Staats, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Mak</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ainsworth Institute of Pain Management</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Molina</last_name>
      <phone>212-203-2813</phone>
    </contact>
    <investigator>
      <last_name>Corey Hunter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Promila Pagadala, PhD</last_name>
      <phone>919-681-9997</phone>
      <email>p.pagadala@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Nandan Lad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Clinical Research, LLC</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Whitney Thompson</last_name>
      <phone>336-765-6181</phone>
      <email>wthompson@ccrpain.com</email>
    </contact>
    <investigator>
      <last_name>Leonardo Kapural, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital &amp; Health Network</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah Bryant</last_name>
      <phone>484-892-2981</phone>
    </contact>
    <investigator>
      <last_name>Steven Falowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DNA Advanced Pain Treatment</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Schleifer</last_name>
      <phone>412-407-3675</phone>
    </contact>
    <investigator>
      <last_name>Yeshvant Navalgund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Center for Advanced Management of Pain</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Williams</last_name>
      <phone>864-764-1570</phone>
      <email>kimw2685@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kelby Hutcheson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vertex Spine and Pain</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Fisher</last_name>
      <phone>615-305-3700</phone>
      <email>lfisher@cpspain.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Rupert, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprehensive Pain Specialists - Hendersonville</name>
      <address>
        <city>Hendersonville</city>
        <state>Tennessee</state>
        <zip>37075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Fisher</last_name>
      <phone>615-305-3700</phone>
      <email>lfisher@cpspain.com</email>
    </contact>
    <investigator>
      <last_name>Peter Kroll</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>El Paso Pain Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisol Serrana</last_name>
      <phone>915-258-4333</phone>
      <email>marisolserrano.eppc@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Anthony Han, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Pain Solutions</name>
      <address>
        <city>Mesquite</city>
        <state>Texas</state>
        <zip>75150</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madison Krueger</last_name>
      <phone>972-681-7246</phone>
      <email>mkrueger.aps@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nagaraj Kikkeri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shannon Clinic</name>
      <address>
        <city>San Angelo</city>
        <state>Texas</state>
        <zip>76903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Wheless</last_name>
      <phone>325-481-2131</phone>
      <email>amandawheless@shannonhealth.org</email>
    </contact>
    <investigator>
      <last_name>Luis Duarte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 7, 2017</lastchanged_date>
  <firstreceived_date>June 7, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Complex Regional Pain Syndromes</mesh_term>
    <mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
